“Efficacy of Empagliflozin in Slowing the Progression of Renal Disease in Patients with Type 2 Diabetes: Single-Blind Interventional Study with Placebo Control at Tertiary Care Setting Quetta”, L&S, vol. 6, no. 4, p. 06, Oct. 2025, doi: 10.37185/LnS.1.1.870.